Decompensated Liver Cirrhosis
Understanding Decompensated Liver Cirrhosis, also known as Decompensated Hepatic Cirrhosis or Advanced Liver Cirrhosis, is crucial for accurate clinical documentation and medical coding. This page provides information on diagnosis, treatment, and management of decompensated cirrhosis, including relevant ICD-10 codes and healthcare guidelines. Learn about the complications of decompensated liver disease, such as hepatic encephalopathy, ascites, and variceal bleeding, and explore resources for patients and healthcare professionals.
Scarring of the liver leading to loss of function and complications.
Jaundice, ascites, hepatic encephalopathy, variceal bleeding.
Hospital inpatient, outpatient hepatology clinic, emergency room.
ICD-10 Code Families
Complete code families applicable to K74.60
When to use each related code
| Description | When to use |
|---|---|
| Advanced liver disease with complications. | Use for cirrhosis with varices, ascites, encephalopathy, or other decompensation signs. |
| Scarring of the liver without major complications. | Compensated cirrhosis: patients without varices, ascites, or encephalopathy. Prioritize based on etiology. |
| Liver inflammation, various causes. | Acute or chronic liver inflammation due to alcohol, virus, autoimmune disease, etc. Code etiology specifically if known. |
Best-practice checklist
- ✓Document Child-Pugh score and class.
- ✓Specify etiology of cirrhosis (e.g., alcohol, NASH).
- ✓Record ascites, varices, encephalopathy details.
- ✓Document MELD score for transplant assessment.
- ✓Include relevant lab results (INR, bilirubin, creatinine).
Common pitfalls to avoid
Risk of inaccurate coding due to unspecified decompensation (e.g., ascites, variceal bleeding). Proper documentation of complications is crucial for accurate code assignment.
Miscoding hepatic encephalopathy (HE) vs. minimal hepatic encephalopathy (MHE). Clear documentation differentiating HE and MHE is essential for correct coding.
Missing documentation of the underlying cause of liver cirrhosis (e.g., alcohol, hepatitis C). Complete documentation of etiology improves coding accuracy and risk adjustment.
Best-practice tips
- 01ICD-10-CM K74.6, K70.3, I85.0: Code specific complications.
- 02HCC coding: Capture MELD score for accurate risk adjustment.
- 03Document ascites, variceal bleeding, encephalopathy for CDI.
- 04Monitor lactulose, antibiotics for hepatic encephalopathy management.
- 05Nutrition support: Optimize protein intake, manage malnutrition.
Step-by-step checklist
- 1
Verify ascites, variceal bleeding, hepatic encephalopathy, or jaundice documented.
- 2
Check MELD score calculation for severity assessment and coding accuracy.
- 3
Confirm ICD-10-CM code (e.g., K74.60, I85.0) matches documentation.
- 4
Review medication list for potential drug-induced liver injury interactions.
Ready-to-paste narrative
Patient presents with decompensated liver cirrhosis, manifested by ascites requiring paracentesis and hepatic encephalopathy. History includes chronic hepatitis C infection, diagnosed in 2005, and long-term alcohol use. Physical examination reveals jaundice, spider angiomata, and palmar erythema. Abdominal examination demonstrates significant ascites and splenomegaly. Neurological examination shows asterixis and mild confusion. Laboratory findings indicate elevated bilirubin, prolonged prothrombin time, decreased albumin, and elevated ammonia levels. Imaging studies, including abdominal ultrasound and prior CT abdomen, confirm cirrhosis with portal hypertension and splenomegaly. Diagnosis of decompensated hepatic cirrhosis is based on clinical presentation, laboratory data, and imaging findings. Assessment includes Child-Pugh score calculation for severity stratification and MELD score for prognosis. Plan includes diuretic therapy for ascites management, lactulose for hepatic encephalopathy, nutritional support, and referral for liver transplant evaluation. Patient education provided regarding disease management, complications of cirrhosis including variceal bleeding and hepatorenal syndrome, and the importance of abstinence from alcohol. Follow-up scheduled in two weeks to monitor response to therapy and assess for further decompensation.
Common questions and answers
What are the key clinical manifestations that differentiate compensated from decompensated liver cirrhosis in patients with chronic liver disease?+
Differentiating compensated from decompensated liver cirrhosis is crucial for effective management. Compensated cirrhosis is often asymptomatic or presents with nonspecific symptoms like fatigue and mild abdominal discomfort. However, decompensated cirrhosis is characterized by overt clinical manifestations such as variceal bleeding, ascites, hepatic encephalopathy, jaundice, spontaneous bacterial peritonitis, and hepatorenal syndrome. These complications signify a decline in liver function and a poorer prognosis. The presence of these clinical signs signals the need for escalated management strategies and closer monitoring. Consider implementing a systematic approach to assess for these manifestations in patients with chronic liver disease to ensure timely intervention and prevent further deterioration. Explore how our advanced diagnostic tools can aid in early detection of decompensation.
How do I effectively manage ascites and hepatic encephalopathy in a patient with decompensated hepatic cirrhosis based on current clinical practice guidelines?+
Managing ascites and hepatic encephalopathy in decompensated hepatic cirrhosis requires a multi-pronged approach based on current clinical practice guidelines. For ascites, sodium restriction and diuretics (e.g., spironolactone and furosemide) are the first line of treatment. Large-volume paracentesis can be considered for tense ascites causing respiratory compromise. In cases of refractory ascites, transjugular intrahepatic portosystemic shunt (TIPS) may be an option. Hepatic encephalopathy management involves identifying and treating precipitating factors such as infections, gastrointestinal bleeding, and electrolyte imbalances. Lactulose and rifaximin are commonly used to reduce ammonia levels. Regular monitoring of ammonia levels and neurological status is critical. Learn more about the latest advancements in managing these complications to optimize patient outcomes.
What prognostic scoring systems are most accurate for risk stratification in patients diagnosed with advanced liver cirrhosis and how can I integrate these into my practice?+
Accurate risk stratification is crucial for determining prognosis and treatment strategies in advanced liver cirrhosis. The Child-Pugh-Turcotte (CPT) score and the Model for End-Stage Liver Disease (MELD) score are commonly used prognostic scoring systems. The CPT score assesses encephalopathy, ascites, bilirubin, albumin, and prothrombin time. The MELD score incorporates serum creatinine, bilirubin, and INR and is particularly useful for prioritizing patients for liver transplantation. Integrating these scoring systems into your practice involves regular assessment of the relevant clinical and laboratory parameters. These scores can help inform discussions about prognosis, treatment options, and the potential need for referral for liver transplantation. Explore how our clinical decision support tools can seamlessly integrate these scoring systems into your workflow.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.